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Abstract
Breast cancer is the most common form of cancer in women and the leading cause of cancer 
death in American women, with over 207,090 new cases of invasive breast cancer in women 
and about 39,840 deaths from breast cancer in 2010. Current therapies for breast cancer usu-
ally have variable effectiveness with high toxicity to normal tissues, and breast tumours often 
develop metastasis and drug resistance. Therefore, searching for effective regimens with mini-
mal side effects remains the top priority in breast cancer research. The objectives of this study 
were to evaluate the effects of tanshinone II from a Chinese herb, Salvia miltiorrhiza, on the 
growth of breast cancer cells type MCF-7 and MDA-MB-231.
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Introduction
The extensive chemical diversity of nature provides models and ideas for mod-
ern drug design. Naturally occurring compounds consist of structures selected by 
evolutionary processes to interact with a wide variety of proteins and other biologi-
cal targets for specific purposes (Yang and Dou, 2010). The use of natural bioactive 
molecules as modulators of cellular pathways is therapeutically advantageous for sev-
eral reasons: the selective perturbation of specific features, the temporal control and 
the reversibility of their action on cell function are all benefits of using natural com-
pounds. On the other hand, the disadvantages may be lack of specificity and cyto-
toxicity. Natural bioactive molecules play a significant role in cancer since more than 
60% of currently available anticancer drugs are natural compounds or are related to 
them (Gordaliza, 2007). As an example, docetaxel, a second-generation taxane, is one 
of the most powerful drugs against breast cancer (Saloustros et al., 2008). In devel-
oped countries, breast cancer diseases are the second mortality cause after cardiovas-
cular diseases. Current therapies for breast cancer usually have variable effectiveness 
with high toxicity to normal tissues, and breast tumours often develop metastasis 
and drug resistance. Therefore, searching for effective regimens with minimal side 
effects remains the top priority in breast cancer research. Danshen (Salvia miltiorrhiza 
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Bunge) has been widely used in traditional Chinese medicine practice for centuries in 
the treatment of coronary artery disease and cerebrovascular diseases with minimal 
side effects. In addition to some 20 phenolic acids, 30 diterpene compounds, includ-
ing the relatively abundant tanshinones (tanshinone I, tanshinone IIA, cryptotanshi-
none, dihydrotanshinone and tanshinone II), have been isolated from Danshen (Zhou 
et al., 2005). In addition to their functions in cardiovascular systems, tanshinones have 
been recently shown to possess some activities against human cancer cells. They are 
the major diterpenes isolated from Danshen and show cytotoxic effects on cell lines 
derived from various human carcinomas of the colon, ovary, liver, neuroglia, lung 
and mouth (Yuan et al,, 2004; Nizamutnova et al., 2008; Yuxian et al., 2009; Lee et al., 
2010; Zhang et al., 2010). It is well documented that tanshinone II can induce apopto-
sis in some human cancer cells, such as leukemia (Sung et al., 1999), human hepato-
cellular carcinoma (Yuan et al., 2002), and nasopharyngeal carcinoma cells. However, 
the molecular mechanisms are not yet elucidated. The objectives of this study were 
to evaluate the activity of tanshinone type II in inhibiting the growth of breast cancer 
cells type MCF-7 and MDA-MB-231, with the aim of identifying the mechanisms by 
which tanshinone type II regulates the expression of functional targets.
Materials and methods
Extraction of tanshinone II
The crude tanshinone II used in the present investigation was obtained by extrac-
tion with ethanol and n-hexane (1:1, v/v) from S. milthiorriza Bunge. Preparative 
high speed counter current chromatography (Dynaminc extractions, Slough, UK) 
with two phase solvent systems composed of n-hexane-ethanol-water (10:7:3, v/v) 
was successfully performed in a stepwise elution yielding six relatively pure diter-
penoids from 300 mg of the crude extract in a single run. The tanshinone II struc-
ture was elucidated by 1D and 2D nuclear magnetic resonance spectroscopy (Agilent 
Technologies, Santa Clara, CA) as well as electrospray ionization mass spectrometry 
(Agilent Technologies) and comparison with published data.
Cell culture
The human, hormone-independent MDA-MB-231 and the hormone-dependent 
MCF-7 breast cancer cell lines were purchased from American Type Culture Collec-
tion (ATCC, Manassas, VA). The cells were placed into 75 cm3 tissue culture flasks 
and grown at 37 °C in a humidified atmosphere, in RPMI-1640 medium (Sigma, 
Milan, Italy), containing 10% heat-inactivated FBS, 1% penicillin-streptomycin (10,000 
U/ ml penicillin and 10 mg/ml streptomycin; Sigma). The data presented in this 
report are from a minimum of three independent experiments.
Cell viability assay
Viability of MDA-MB-231 and MCF-7 cells in response to tanshinone II was tested 
in dose (0, 1, 10, 100 μmol/l) and time dependent experiments for four days. Cells at 
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the exponential phase of growth were seeded at 104 cells/well in 24 well plates. After 
different treatments, the amount of viable cells was estimated by MTT assay as follows: 
20 µl of 5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 
Sigma) solution were added to each well and incubated for 4 h. The supernatants were 
aspirated and the formazan crystals in each well were dissolved in DMSO (Sigma) and 
absorbance at 570 nm was read on a microplate reader (Bio-Rad, Hercules, CA).
Western blot analysis
Breast cancer cells types MDA-Mb-231 and MCF-7 were treated with 10 μM tan-
shinone II for various periods and lysed in lysis buffer (10 mmol/l Tris, pH 8.0, 120 
mmol/l NaCl, 0.5% w/v Nonidet P-40, 1 mmol/l EDTA, and protease inhibitors, i.e. 
0.1 mmol/l phenylmethylsulfonyl fluoride, 1 mmol/l dithiothreitol, and 1 mg/ml 
aprotinin) on ice for 30 min. The lysate was centrifuged at 16,873 × g (Beckman Coul-
ter Inc.) for 20 min. The supernatant was subjected to 15% SDS-polyacrylamide gel 
electrophoresis. After transfer of proteins in the gel to a membrane, the membrane 
was incubated with antibodies for caspase-3, Bax and Bcl2 (1:1,000) and then with 
horseradish peroxidase-linked secondary antibody and the enhanced chemilumines-
cence (ECL) detection kit (Amersham, Piscataway, NJ). Protein concentrations were 
determined with a protein assay kit (Bio-Rad). The amount of target proteins was 
normalized to the structural protein (tubulin) to control between groups.
Statistical analysis
Values are presented as a mean ± standard deviation (SD). Student’s t-test was 
used to analyze the statistical significance and p<0.05 was considered significant for 
all tests.
Results 
As shown in Figs. 1a and 1b it was clearly observed that tanshinone II significant-
ly inhibited the viability of MDA-MB-231 and MCF-7 cell lines. These results were 
confirmed by morphological analysis of cell growth inhibition observed under a light 
microscope (Figs. 2a-h). However, with increasing incubation time, a concentration 
of 100 µmol/l of tanshinone II significantly decreased cell viability. Tanshinone II 
induced cytotoxicity more effectively in MDA-MB-231 than in MCF-7. To examine if 
tanshinone II (100 µmol/l) induced cytotoxicity was due to the induction of apoptotic 
cell death in both cancer cell lines, the levels of the apoptosis- associated proteins, 
Bcl-2, Bax, and cleaved caspase-3, were detected by western blot analysis. As shown 
in Figs. 3a,b, tanshinone II (4 days) at a dose of 100 µmol/l increased the levels of 
caspase 3 cleaved forms in both breast cancer cell lines. Interestingly, and in agree-
ment with the results of MTT test, 100 µmol/l tanshinone II more effectively induced 
the cleaved form of caspase-3 in MDA-MB-231 than in MCF-7 cells..Moreover, west-
ern blot analysis showed that tanshinone II increased pro-apoptotic Bax protein levels 
and decreased anti-apoptotic Bcl-2 levels in parallel in MCF-7 and MDA-MB-231 cells 
(Figs. 4a,b).
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Discussion
Breast cancer is the most common neoplasm in women in both developed and 
developing countries. The human breast cancer cell line, MCF-7, is estrogen recep-
tor (ER)-positive, but approximately one-third of breast cancers are ER-negative, 
Figure 1a,b – Tanshinone II suppresses cell viabilities of estrogen receptor negative MDA-MB-231 cells (estro-
gen receptor-negative). The effect of tanshinone II on cell viability was measured in a concentration- and 
time-dependent manner by MTT. MDA-MB-231 cells were incubated with tanshinone II for 1, 2, 3 and 4 days. 
It was observed that tanshinone II significantly decreased cell viabilities of cells in a concentration- and time-
dependent manner. The data represents the mean ±SD of 3 separate experiments performed in triplicate.
1a 1b
Figure 2 – Morphological analysis by phase contrast light microscopy of the growth inhibition of MDA-
MB-231 cells (a-e) and MCF-7 cells (f-l) after treatment with 100 μmol(L tanshinone II .
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with the latter carrying a worse prognosis leading to distant metastases. Therefore, it 
is important to identify new agents that are effective in both ER-positive and -nega-
tive breast cancer. Our results demonstrate that tanshinone II not only has a pow-
erful inhibitory effect on the proliferation of ER-positive human breast cancer cells, 
but also significantly inhibits the growth of human ER-negative cells in vitro. Herbal 
medications are now used in cancer therapy and several plant-derived compounds 
are used successfully in clinical practice. The roots of Salvia miltiorrhiza Bunge, gen-
erally known as Danshen, have been used in Chinese traditional medicine to treat 
cardiovascular disorders and hepatitis in Asia for thousands of years. The major bio-
active compounds of Danshen, tanshinone I, tanshinone IIA and cryptotanshinone, 
exhibit diverse biological effects such as antibacterial, antioxidative and anti-inflam-
matory activity, cytotoxicity and inhibition of platelet aggregation. In this study we 
found that another bioactive compound of Danshen family such as tanshinone II may 
exert an inhibitory effect on cell availability in human breast cancer cells by induc-
tion of apoptotic cell death. The anti proliferative effect of Tanshinone II probably is 
mediated by induction of apoptosis process due to the activation of caspase-3 signal. 
The activation of apoptosis contributes to the suppression of malignant transforma-
tion, and has been characterized as a fundamental cellular activity for preventing 
neoplastic development by eliminating genetically damaged cells, or cells that have 
been improperly induced to divide by a mitotic stimulus. Thus, induction of apopto-
sis in cancer cells has become an indicator of cancer treatment response and may hint 
to reduction of mortality in patients. To reach this goal we have treated two different 
breast cancer cell lines with Tanshinone II, with the aim to understand if this natural 
bioactive compound could affect their availability. Our results demonstrate that tan-
Figure 3 – Tanshinone II activates the caspase-3 pathway in breast cancer cells. Cells were treated with tan-
shinone II in a concentration-dependent manner for 4 days as described in Materials and methods, and total 
proteins were extracted.
Figure 4 – Tanshinone II activates decreases the Bcl-2/Bax ratio in breast cancer cells in a time-dependent 
manner.
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shinone II not only has an inhibitory effect on the proliferation of ER-positive (MCF-
7) human breast cancer cells, but also significantly inhibits the growth of human ER-
negative cells (MDA-MB-231) in vitro. The effect of Tanshinone II is mediated by the 
induction of apoptosis, which is associated with caspase-3 activation and Bcl2 –Bax 
proteins, in MCF-7 and MDA- MB-231 cells. Thus, it is reasonable to suggest that the 
apoptotic potential of tanshinone II is directly related to its ability to alter the ratio 
of pro-apoptotic to anti-apoptotic proteins in targeted cells. In conclusion, this study 
determined an anti-cancer effect of tanshinone II mediated by the induction of apop-
tosis, which is associated with caspase-3 activation and an altered ratio between Bcl-2 
and Bax protein levels, in MCF-7 and MDA- MB-231 cells.
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